Qynapse

The future of neuroimaging analysis is here and Qynapse is leading the way. For clinicians on the front lines, for patients and their families, for payers, and for pharma we offer peace of mind by providing results you can trust. Headquartered in France, in the United States and in Canada, the Qynapse team, with our world-renowned team of scientific and clinical partners, is wholly dedicated to aspiring to bring the entire neuroscience community and their patients the clearest, most accurate and reliable predictors and objective measures of devastating CNS disorders such as Alzheimers disease, multiple sclerosis and Parkinsons disease. We...

Medical device,neurology,neuroimaging,artificial intelligence,diagnosis,prediction,disease trajectory,monitoring,drug efficacy,drug safety,personalized medicine,clinical trials,clinical research,central nervous system,azheimer's,parkinson's,dementia,multiple sclerosis,stroke,and psychiatry

Qynapse operates in the Medical equipment manufacturing industry.

Qynapse's revenue is 11m - 100m

Qynapse has 11 - 50 employees.